Advertisement
Home »

Adjuvant Ribociclib Improves Invasive Disease-Free Survival in Early Breast Cancer

Jun 12, 2023

REFERENCES & ADDITIONAL READING

Harbeck N, et al. Ther Adv Med Oncol. 2020;12:1758835920943065.

Pan H, et al. N Engl J Med. 2017;377:1836–1846.

Slamon DJ, et al. Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer: primary results from the phase III NATALEE trial. Abstract LBA500. ASCO Annual Meeting 2023, 2–6 June, Chicago.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement